Figure 1
Cumulative incidence of invasive aspergillosis and OS estimate at 36 months after HSCT according to DECTIN1 Y238X genotype. (A) Cumulative incidence according to donor genotype: WT (19%, N = 150, reference) and Y238X (38%, N = 29; P = .03). (B) Cumulative incidence according to recipient genotype: WT (20%, N = 157; reference) and Y238X (39%, N = 22; P = .11). (C) Cumulative incidence according to donor/recipient pair genotype: WT (18%, N = 140; reference), donor Y238X and recipient WT (35%, N = 17; P = .07), donor WT and recipient Y238X (33%, N = 10; P = .38), and Y238X (44%, N = 12; P = .05). (D) OS according to donor/recipient pair genotype: WT (41%, N = 153; reference), donor Y238X and recipient WT (32%, N = 22; P = .38), donor WT and recipient Y238X (32%, N = 15; P = .57), and Y238X (23%, N = 15; P = .51).

Cumulative incidence of invasive aspergillosis and OS estimate at 36 months after HSCT according to DECTIN1 Y238X genotype. (A) Cumulative incidence according to donor genotype: WT (19%, N = 150, reference) and Y238X (38%, N = 29; P = .03). (B) Cumulative incidence according to recipient genotype: WT (20%, N = 157; reference) and Y238X (39%, N = 22; P = .11). (C) Cumulative incidence according to donor/recipient pair genotype: WT (18%, N = 140; reference), donor Y238X and recipient WT (35%, N = 17; P = .07), donor WT and recipient Y238X (33%, N = 10; P = .38), and Y238X (44%, N = 12; P = .05). (D) OS according to donor/recipient pair genotype: WT (41%, N = 153; reference), donor Y238X and recipient WT (32%, N = 22; P = .38), donor WT and recipient Y238X (32%, N = 15; P = .57), and Y238X (23%, N = 15; P = .51).

Close Modal

or Create an Account

Close Modal
Close Modal